Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Verastem (VSTM) Research & Development (2018 - 2025)

Historic Research & Development for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $29.0 million.

  • Verastem's Research & Development rose 1710.83% to $29.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.7 million, marking a year-over-year increase of 3930.36%. This contributed to the annual value of $81.3 million for FY2024, which is 3256.08% up from last year.
  • Per Verastem's latest filing, its Research & Development stood at $29.0 million for Q3 2025, which was up 1710.83% from $24.8 million recorded in Q2 2025.
  • Verastem's Research & Development's 5-year high stood at $29.2 million during Q1 2025, with a 5-year trough of $8.9 million in Q1 2021.
  • Its 5-year average for Research & Development is $16.3 million, with a median of $13.8 million in 2022.
  • Its Research & Development has fluctuated over the past 5 years, first crashed by 1856.46% in 2021, then surged by 7749.89% in 2024.
  • Verastem's Research & Development (Quarter) stood at $11.4 million in 2021, then decreased by 5.76% to $10.7 million in 2022, then rose by 29.85% to $13.9 million in 2023, then skyrocketed by 49.23% to $20.8 million in 2024, then skyrocketed by 39.3% to $29.0 million in 2025.
  • Its last three reported values are $29.0 million in Q3 2025, $24.8 million for Q2 2025, and $29.2 million during Q1 2025.